People with eating disorders cannot take these drugs at all
"I think it is important that safety is first if there is any indication of any adverse effects that are concerning and are serious, that any health authority ought to look into it in a serious manner," said Dr
Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: GIP (gastric inhibitory polypeptide) receptor GLP-1 (glucagon-like peptide-1) receptor GCG (glucagon) receptor This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications
10.2174/0115748871323540241212060946 41 FangJ.KohJ.FangQ.QiuH.ArchangM
Tu D, Gao Y, Yang R, Guan T, Hong J-S, Gao H-M
It mimics the physiological process and is subjected to feedback mechanisms, thus preventing adverse effects like improper dosing and disruption of normal processes